Effect of repetitive glucose spike and hypoglycaemia on atherosclerosis and death rate in Apo E-deficient mice

International Journal of Endocrinology

Volumn 2015, Issue , 2015, Pages

  Nakajima, Kenichi ^a   Mita, Tomoya ^a   Osonoi, Yusuke ^a   Azuma, Kosuke ^a   Takasu, Toshiyuki ^b   Fujitani, Yoshio ^a   Watada, Hirotaka ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; GLUCOSE; INSULIN; IPRAGLIFLOZIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; HYPOGLYCEMIA; MALE; MORTALITY; MOUSE; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN DEPLETION; REPETITIVE GLUCOSE SPIKE; REPETITIVE HYPOGLYCEMIA; SURVIVAL RATE;

EID: 84940770593     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2015/406394     Document Type: Article

References (33)

1. The DECODE Study Group on Behalf of the European Diabetes Epidemiology Group, "Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria," The Lancet, vol. 354, no. 9179, pp. 617-621, 1999.
2. T. Nakagami, "Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin," Diabetologia, vol. 47, no. 3, pp. 385-394, 2004.
3. A. Otsuka, K. Azuma, T. Iesaki et al., "Temporary hyperglycaemia provokes monocyte adhesion to endothelial cells in rat thoracic aorta," Diabetologia, vol. 48, no. 12, pp. 2667-2674, 2005.
4. T. Mita, A. Otsuka, K. Azuma et al., "Swings in blood glucose levels accelerate atherogenesis in apolipoprotein E-deficient mice," Biochemical and Biophysical Research Communications, vol. 358, no. 3, pp. 679-685, 2007.
5. L. Quagliaro, L. Piconi, R. Assaloni, L. Martinelli, E. Motz, and A. Ceriello, "Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation," Diabetes, vol. 52, no. 11, pp. 2795-2804, 2003.
6. A. Ceriello, K. Esposito, L. Piconi et al., "Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients," Diabetes, vol. 57, no. 5, pp. 1349-1354, 2008.
7. I. Raz, G. Jermendy, P. W. F. Wilson et al., "Effects of prand ial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial," Diabetes Care, vol. 32, no. 3, pp. 381-386, 2009.
8. A. Patel, S. MacMahon, J. Chalmers et al., "Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes," The New England Journal of Medicine, vol. 358, no. 24, pp. 2560-2572, 2008.
9. W. Duckworth, C. Abraira, T. Moritz et al., "Glucose control and vascular complications in veterans with type 2 diabetes," The New England Journal of Medicine, vol. 360, no. 2, pp. 129-139, 2009.
10. H. C. Gerstein, M. E. Miller, R. P. Byington et al., "Effects of intensive glucose lowering in type 2 diabetes," The New England Journal of Medicine, vol. 358, pp. 2545-2559, 2008.
11. K. Khunti, M. Davies, A. Majeed, B. L. Thorsted, M. L. Wolden, and S. K. Paul, "Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study," Diabetes Care, vol. 38, no. 2, pp. 316-322, 2015.
12. B. M. Frier, R. J. M. Corrall, N. M. Davidson, R. G. Webber, A. Dewar, and E. B. French, "Peripheral blood cell changes in response to acute hypoglycaemia in man," European Journal of Clinical Investigation, vol. 13, no. 1, pp. 33-39, 1983.
13. A. Collier, A. W. Patrick, D. A. Hepburn et al., "Leucocyte mobilization and release of neutrophil elastase following acute insulin-induced hypoglycaemia in normal humans," Diabetic Medicine, vol. 7, no. 6, pp. 506-509, 1990.
14. P. J. Galloway, G. A. Thomson, B. M. Fisher, and C. G. Semple, Insulin-induced hypoglycemia induces a rise in C-reactive protein," Diabetes Care, vol. 23, no. 6, pp. 861-862, 2000.
15. A. E. Kitabchi, G. E. Umpierrez, J. M. Miles, and J. N. Fisher, Hyperglycemic crises in adult patients with diabetes," Diabetes Care, vol. 32, no. 7, pp. 1335-1343, 2009.
16. J. Dalsgaard-Nielsen, S. Madsbad, and J. Hilsted, "Changes in platelet function, blood coagulation and fibrinolysis during insulin-induced hypoglycaemia in juvenile diabetics and normal subjects," Thrombosis and Haemostasis, vol. 47, no. 3, pp. 254-258, 1982.
17. B. M. Fisher, D. A. Hepburn, J. G. Smith, and B. M. Frier, Responses of peripheral blood cells to acute insulin-induced hypoglycaemia in humans: effect of alpha-adrenergic blockade," Hormone and Metabolic Research, Supplement, supplement 26, pp. 109-110, 1992.
18. W. L. Jin, K. Azuma, T. Mita et al., "Repetitive hypoglycaemia increases serum adrenaline and induces monocyte adhesion to the endothelium in rat thoracic aorta," Diabetologia, vol. 54, no. 7, pp. 1921-1929, 2011.
19. E. Yasunari, T. Mita, Y. Osonoi et al., "Repetitive hypoglycemia increases circulating adrenaline level with resultant worsening of intimal thickening after vascular injury inmale goto-kakizaki rat carotid artery," Endocrinology, vol. 155, no. 6, pp. 2244-2253, 2014.
20. M. Arakawa, T. Mita, K. Azuma et al., "Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4," Diabetes, vol. 59, no. 4, pp. 1030-1037, 2010.
21. T. Mita, H. Goto, K. Azuma et al., "Impact of insulin resistance on enhanced monocyte adhesion to endothelial cells and atherosclerogenesis independent of LDL cholesterol level," Biochemical and Biophysical Research Communications, vol. 395, no. 4, pp. 477-483, 2010.
22. N. Ervinna, T. Mita, E. Yasunari et al., "Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice," Endocrinology, vol. 154, no. 3, pp. 1260-1270, 2013.
23. I. Sabolic, I. Vrhovac, D. B. Eror et al., "Expression of Na+-Dglucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences," The American Journal of Physiology Cell physiology: Cell Physiology, vol. 302, pp. 1174-1188, 2012.
24. F. M. Hasan, M. Alsahli, and J. E. Gerich, "SGLT2 inhibitors in the treatment of type 2 diabetes," Diabetes Research and Clinical Practice, vol. 104, no. 3, pp. 297-322, 2014.
25. A. Tanaka, K. Azuma, Y. Toyofuku et al., "Insulin and nateglinide reduce monocyte adhesion to endothelial cells in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation," Biochemical and Biophysical Research Communications, vol. 350, no. 1, pp. 195-201, 2006.
26. R. V. Oliva and G. L. Bakris, "Blood pressure effects of sodiumglucose co-transport 2 (SGLT2) inhibitors," Journal of the American Society of Hypertension, vol. 8, no. 5, pp. 330-339, 2014.
27. E. R. Seaquist, M. E. Miller, D. E. Bonds et al., "The impact of frequent and unrecognized hypoglycemia on mortality in the ACCORDstudy," Diabetes Care, vol. 35, no. 2, pp. 409-414, 2012.
28. S. Zoungas, A. Patel, J. Chalmers et al., "Severe hypoglycemia and risks of vascular events and death," The New England Journal of Medicine, vol. 363, no. 15, pp. 1410-1418, 2010.
29. D. E. Bonds, M. E. Miller, R. M. Bergenstal et al., "The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study," British Medical Journal, vol. 340, Article ID b4909, 2010.
30. P. Hamet, "What matters in ADVANCE and ADVANCE-ON," Diabetes, Obesity & Metabolism, vol. 14, supplement 1, pp. 20-29, 2012.
31. G. Gruden, S. Giunti, F. Barutta et al., "QTc interval prolongation is independently associated with severe hypoglycemic attacks in type 1 diabetes from the EURODIAB IDDM complications study," Diabetes Care, vol. 35, no. 1, pp. 125-127, 2012.
32. T. Matoba, K. Sato, and K. Egashira, "Mouse models of plaque rupture," Current Opinion in Lipidology, vol. 24, no. 5, pp. 419-425, 2013.
33. H. Sugimoto, D. J. Franks, L. Lecavalier, J.-L. Chiasson, and P. Hamet, "Therapeuticmodulation of growth-promoting activity in platelets fromdiabetics," Diabetes, vol. 36, no. 5, pp. 667-672, 1987.